Alcoholic Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Alcoholic Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease [NA]
Clinical trial from Massachusetts General Hospital investigates financial rewards to reduce alcohol use in patients with alcohol-related liv…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States [Phase 2]
Phase 2 clinical trial to evaluate the efficacy and safety of rosuvastatin for liver cirrhosis in the United States. The study is currently …
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Prevalence of Eating Disorder in Liver Transplant Patients
Completed clinical trial evaluating how prevalent eating disorders are among liver transplant patients, including associations with binge ea…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis [Phase 2]
A Phase 2 dose-finding study assessing the safety and efficacy of stem cell therapy in alcoholic liver cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) [Phase 2]
This document reports the completion of a Phase 2 randomized exploratory trial (REVIVE) evaluating a stem cell product for safety and effect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of mesenchymal stem cell therapy for alcoholic liver cirrhosis is being updated.